A recent study found that CCM can inhibit the expression of Nicotinamide N-methyltransferase (NNMT) and p-STAT3 in CRC cells and attenuate NNMT-induced resistance to 5-FU (145). The gene discussed is STAT3; the disease is colorectal carcinoma.